Liyong Pu

Title: Liyong Pu: Innovator in Adipose Tissue-Targeting Drug Delivery

Introduction

Liyong Pu is a notable inventor based in Nanjing, China. He has made significant contributions to the field of drug delivery systems, particularly in targeting adipose tissue for obesity treatment. His innovative approach combines biocompatibility with effective drug delivery mechanisms.

Latest Patents

Liyong Pu holds a patent for an "Adipose tissue-targeting polypeptide-verbascoside-nanogold particle derivative, preparation method and application thereof." This patent outlines a method for preparing a derivative that enhances drug delivery to adipocytes, thereby improving the efficacy of anti-obesity drugs. The method involves activating a carboxyl group of a cysteine residue, esterifying with sodium phenolate, and reacting with PEG-modified nanogold particles. The resulting derivative demonstrates good biocompatibility and significantly enhances the targeted anti-obesity activity of the drug.

Career Highlights

Liyong Pu has worked at the Affiliated Stomatological Hospital of Nanjing Medical University and Nanjing Medical University. His experience in these institutions has contributed to his research and development in the field of medical innovations.

Collaborations

Liyong Pu has collaborated with notable colleagues such as Yi Yuan and Yaqin Zhang. Their combined expertise has further advanced the research and applications of his patented technologies.

Conclusion

Liyong Pu's innovative work in adipose tissue-targeting drug delivery systems represents a significant advancement in obesity treatment. His contributions are paving the way for more effective therapeutic options in the medical field.